VDR and cancer: 1α,25-dihydroxyvitamin D3 (VD3, also known as calcitriol), activated by binding to nuclear vitamin D receptor (VDR) in the genomic way, displays its wide-ranging effects on a variety of cancers (Jeon and Shin, 2018; Carlberg and Munoz, 2020).